Izithako nokusetshenziswa
I-inhalers ye-chronic obstructive pulmonary disease (COPD) iyindlela yokwelashwa okuyisisekelo, kodwa ukuqonda ukuhlukahluka phakathi kwe-inhalers ehlukene ngezinye izikhathi kungadideka.
Izinhlobo ze-COPD Inhalers
I-COPD inhalers ingaqukatha noma imithi eyodwa noma inhlanganisela yemithi. I-inhaler ingaba:
- i-bronchodilator, esiza ukuvula imimoya yakho futhi ukwandise ukugeleza komoya
- i-corticosteroid, esiza ukunciphisa ukuvuvukala emoyeni wakho
- inhlanganisela yama-bronchodilators ahlukene
- inhlanganisela ye-bronchodilator ne-corticosteroid
I-10 Eningi Ejwayelekile Yama-Inhalers E-Common
Nakhu okujwayelekile kakhulu kwe-COPD emakethe namuhla. Uma ucabanga ukuthi ungase uzuze uhlobo oluthile lwe-inhaler kunalokho obekiwe, xoxa nodokotela wakho mayelana nokukhathazeka kwakho.
1 -
I-AdvairI-Advair iyinhlanganisela yemithi emibili: i-fluticasone, i-corticosteroid, ne-salmeterol, i-bronchodilator ende. I-Advair isetshenziselwa ukwelashwa kwesondlo kwe-COPD .
2 -
I-SymbicortEkuqaleni esetshenziselwa ukwelashwa kwe-asthma, iSymbicort yamukelwa yi-Food and Drug Administration (FDA) ngoFebruwari 2009 yokwelashwa kwe-COPD. I-Symbicort iqukethe i-formoterol, i-bronchodilator ende esebenza isikhathi eside, ne-budesonide, i-corticosteroid.
3 -
Ukuziphendulela okuningiInqwaba iqukethe ama- bronchodilator amabili: i-albuterol (i-beta-agonist-beta agonists isiza imisipha ejikeleze umoya wakho ukuphumula) kanye ne-ipratropium (i-anticholinergic-uhlobo oluthile lwesidakamizwa olusiza izidumbu ezungeze imimoya yakho ukuze uphumule).
Inhlanganisela ye-bronchodilator inhalers njenge-Combivent ingasiza ukukhulisa umphumela we-bronchodilator wemithi, nemiphumela emibi efanayo noma embalwa.
4 -
PulmicortI-Pulmicort iqukethe i-budesonide, i-corticosteroid esiza ukunciphisa ukuvuvukala emoyeni, okwenza kube lula ngawe ukuba uphefumule. I-Pulmicort isetshenziselwa ukwelashwa kwesondlo kwe-COPD.
5 -
SpirivaNjengoba isetshenziselwa ukwelashwa kwe-COPD, i- Spiriva iqukethe imithi ebizwa ngokuthi i-tiotropium, i-bronchodilator e-anticholinergic. Ivula futhi ivuselele imimoya yomoya, okwenza kube lula ukuphefumula.
6 -
ProventilI-Proventil iyi-inhaler yokusindisa (ngamanye amazwi, i-inhaler ehlose ukusiza ngokushesha ngezinkinga zokuphefumula) equkethe i-albuterol, i-short-acting, i-beta-agonist bronchodilator. I-Proventil isiza ngokushesha ukuphumula imimoya, okwenza kube lula ukuphefumula. I-Proventil ivame ukusetshenziselwa iziqephu eziphuthumayo zokuphefumula okuhlobene ne-bronchospasm kokubili iziguli ze-asthma kanye ne-COPD.
7 -
AtroventI-Atrovent iqukethe ipratropium, i-bronchodilator ye-anticholinergic. Isetshenziselwa ukwelashwa kwesondlo kwe-COPD.
8 -
BrovanaI-Brovana iyi-bronchodilator ende esebenza isikhathi eside (imithi ye-beta-agonist). Isetshenziselwa ukwelashwa kwesikhashana eside kulabo abaneCOPD ukuphumula imimoya yomoya futhi kwenze kube lula ukuphefumula. Kufanele kuthathwe kabili ngosuku, ekuseni nakusihlwa. I-Brovana ayiyona inhaler yokulondoloza, futhi ayiphathe i-asthma.
9 -
I-Neohaler ye-ArcaptaI-Necaphuna ye-Arcapta yigama lomkhiqizo we-indacaterol inhalation, i-bronchodilator ende ye-beta-agonist ende. Ifika efomini ye-capsule futhi ilawulwa nge-powder inhaler eyomile. Isetshenziselwa ukwelashwa kwesikhashana esisodwa-nsuku zonke, ukwelashwa kwesikhashana sokuvinjelwa kwamanzi ku-COPD , kuhlanganise ne-emphysema ne-bronchitis engapheli. Akuyona inhaler yokutakula, futhi akusho ukuphatha i-asthma.
10 -
Breo ElliptaI-Breo Ellipta iyinhlanganisela yemithi emibili: i-fluticasone furoate, i-corticosteroid ephazamisekile (i-ICS), ne-vilanterol, i-agonist ye-beta2 ende-adrenergic eside (uhlobo lwezidakamizwa ezibuyisela imisipha ezungeze indlela yakho yokuhamba emoyeni futhi ikusiza ukuthi ususe i-mucus). I-Breo Ellipta imithi yokondla yansuku zonke yokwelapha ukuvinjelwa kwamanzi ezigulini ezine-COPD, kuhlanganise ne- emphysema ne- bronchitis engapheli .
> Umthombo:
> Ferguson GT, Yenza B. Ukuphathwa kweSifo esiPhezulu seSifo esiPhezulu esiPhezulu. Kusesikhathini. 2017. Kubuyekezwe ngo-Okthoba 12, 2017.